Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Jan 2026 for CorMedix Inc..
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert A. Stewart: trading record in brief
Robert A. Stewart has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Allergan plc, CorMedix Inc. and Amneal Pharmaceuticals, Inc. We count 13 filings; the first trade dates from 1 February 2017 and the latest from 26 January 2026.
Every open-market trade on record is a purchase: 2 purchases worth €220k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 9 share grants and 2 option exercises.
On 27 January 2026 came the latest disclosure, a share grant in CorMedix Inc. The last insider purchase was made public on 18 May 2023, 1,255 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert A. Stewart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
30,453 shares0Common StockSEC:0001213900-26-008477:0
25,000 shares0Common StockSEC:0001213900-25-005673:0
10,000 shares@ US$4.3735100.0% of flowCommon StockSEC:0000929638-23-001519:0
3 of 3 declarations
